SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-052344
Filing Date
2022-04-28
Accepted
2022-04-28 16:43:49
Documents
9
Period of Report
2022-06-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm223497-1_def14a.htm DEF 14A 930916
2 GRAPHIC tm212498d1-icon_num1bw.jpg GRAPHIC 858
3 GRAPHIC tm212498d1-icon_num2bw.jpg GRAPHIC 864
4 GRAPHIC tm212498d1-icon_num3bw.jpg GRAPHIC 864
5 GRAPHIC tm212498d1-icon_num4bw.jpg GRAPHIC 865
6 GRAPHIC tm2025328d42-icon_arrowbw.jpg GRAPHIC 1761
7 GRAPHIC tm2025328d42-icon_menbw.jpg GRAPHIC 885
8 GRAPHIC tm223497d1-px_01pagebw.jpg GRAPHIC 558763
9 GRAPHIC tm223497d1-px_02pagebw.jpg GRAPHIC 460795
  Complete submission text file 0001104659-22-052344.txt   2345461
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Filer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38492 | Film No.: 22867434
SIC: 2834 Pharmaceutical Preparations